$ABCL is on course for humanity. TCEs excite me quite a lot besides GPCRs. The superiority in g-couples has almost been proven weeks ago after ph2 results. But it’s time for Hansen and the team to deliver T-cell targeted drug to the clinic around ‘27.
Long road to fix and remake
